Browsing: lands

Startup aims to ‘unlock prevention’ by combining images, video, voice and other health data collected by our phones. Berlin-based digital…

Phase 1 dosing milestone for MEN2501 signals growing confidence in generative AI drug discovery and its healthspan implications. There is…

Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…

Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs designed to…

Company aims to extend human healthspan via a combination of preventive RNAi therapeutics and AI-powered risk prediction. Preventive health biotech…

Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology.   Swiss healthtech startup Liom has secured a $16.5 million…

Startup targets ‘brainspan’ with EEG-powered headphones designed to make monitoring cognitive health as normal as heart rate. Consumer neurotech company…

Bets on automation underscore investor confidence in industrializing cell therapies as patient demand continues to outpace supply. Cellular Origins, a…

Initial focus on epilepsy could drive progress in aging and healthspan therapeutics targeting the mTOR pathway. US biotech Aeovian Pharmaceuticals…

Subsense secures additional $10m following progress towards nanoparticle-based approach to neural interface control. Neurotech startup Subsense has expanded its total…